Translational PK/PD for the Development of Novel Antibiotics—A Drug Developer’s Perspective
Caterina Bissantz(Roche (Switzerland)), William Stubbings(Roche (Switzerland)), Pascale David‐Pierson(Roche (Switzerland)), Claudia Zampaloni(Roche (Switzerland)), Andreas Guenther(Universität Hamburg), Guennaëlle Dieppois(Roche (Switzerland)), Lotte Winther(Roche (Switzerland)), Andrej Trauner(Roche (Switzerland))
Cited by 11
Related Papers
A Medicinal Chemist’s Guide to Molecular Interactions
|Journal of Medicinal Chemistry|2010|1.7k
Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)
|Journal of Clinical Oncology|2017|248
A Real-World Perspective on Molecular Design
|Journal of Medicinal Chemistry|2016|120